Kyle Kiser

Kyle Kiser, CEO of Arrive Health, discusses the pressing issue of prescription affordability and the gaps in medication access faced by many Americans. He highlights how point-of-prescribing technology can bridge these gaps and enhance patient care through real-time data. The conversation touches on the evolving role of pharmaceutical support programs and the potential of biosimilars to lower costs. Kiser emphasizes the importance of integrating consumer choice into healthcare decision-making to empower patients and streamline access to necessary medications.